Cryptococcal Meningitis in An Immunocompetent Patient



Abstract Views
355

Downloads
254

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Mar 18, 2023
Published Jun 30, 2023
10.24018/clinicmed.2023.4.3.273

Abstract viewed = 355 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

A fungal illness called cryptococcal meningitis is most often thought of as an opportunistic infection that affects immunocompromised people, typically those who have HIV infection. Numerous problems are linked to it, including widespread illness and neurologic ones such as intracranial hypertension, cerebral infarcts, vision loss, and other abnormalities. Here is a case 18-year-old male patient, who presented with persistent headache and fever. A lumbar puncture revealed a cryptococcal infection in him. His workup indicated no known underlying illness that may have compromised his immune system. CSF was then tested for cryptococcal species using an Indian ink preparation, and the results were positive. He was admitted to the hospital for initiation of antifungal therapy with amphotericin B along with serial serum creatinine and electrolytes levels and after the 5th day of getting amphotericin B, he had shown remarkable improvement in total symptomatology.

Keywords: AIDS CSF cryptococcal meningitis HIV immunocompetent

References

  1. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991; 13(6): 1163-9.
     Google Scholar
  2. Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014; 4(7): a019760.
     Google Scholar
  3. Pescador Ruschel MA, Thapa B. Cryptococcal Meningitis. StatPearls Publishing; 2023.
     Google Scholar
  4. Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, Sinh DX, et al. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam-high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis. 2010; 10(1): 199.
     Google Scholar
  5. Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR. Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing. J Clin Microbiol. 2019; 57(1).
     Google Scholar
  6. Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021; 19(7): 454-66.
     Google Scholar
  7. Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother. 2008; 9(4): 551-60.
     Google Scholar
  8. Su X-H, Li W-P, Lin Q, Zheng X-J, Fang T, Jiang Y, et al. Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient. BMC Neurol. 2022; 22(1): 247.
     Google Scholar
  9. Acharya S, Yadav SK, Singh PB, Bhandari S, Gautam J, Pathak S, et al. Cryptococcal meningitis in an immunocompetent individual: A case report. Clin Case Rep. 2021; 9(10): e04894.
     Google Scholar
  10. Ghasemian R, Najafi N, Shokohi T. Cryptococcal meningitis relapse in an iimmunocompetent patient. Arch Clin Infect Dis [Internet]. 2011; 6(1): 51-5.
     Google Scholar
  11. Vu K, Garcia JA, Gelli A. Cryptococcal meningitis and anti-virulence therapeutic strategies. Front Microbiol. 2019; 10: 353.
     Google Scholar
  12. Poley M, Koubek R, Walsh L, McGillen B. Cryptococcal meningitis in an apparent immunocompetent patient. J Investig Med High Impact Case Rep. 2019; 7: 2324709619834578.
     Google Scholar